308 related articles for article (PubMed ID: 15481703)
1. "Late" regressions of metastases from renal cancer after a period of disease progression continuing the same intermittent low dose immunotherapy regimen.
Giacosa R; Santi R; Vaglio A; Pavone L; Ferrozzi F; Passalacqua R; Buzio C
Acta Biomed; 2004 Aug; 75(2):126-30. PubMed ID: 15481703
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcome of combined immunotherapy with interferon-alpha and low-dose interleukine-2 for Japanese patients with metastatic renal cell carcinoma.
Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Urol Oncol; 2009; 27(6):598-603. PubMed ID: 18818106
[TBL] [Abstract][Full Text] [Related]
3. [Synergetic responses after administration of interleukin-2 and Interferon-alpha combined with gamma knife radiosurgery in a patient with multiple lung and brain metastases: a case report].
Takada T; Yamada Y; Uno M; Komeda H; Fujimoto Y
Hinyokika Kiyo; 2005 Jun; 51(6):381-4. PubMed ID: 16050476
[TBL] [Abstract][Full Text] [Related]
4. Prediction of response to combined immunotherapy with interferon-alpha and low-dose interleukin-2 in metastatic renal cell carcinoma: expression patterns of potential molecular markers in radical nephrectomy specimens.
Miyake H; Sakai I; Muramaki M; Kurahashi T; Takenaka A; Fujisawa M
Int J Urol; 2009 May; 16(5):465-71. PubMed ID: 19467119
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of pulmonary metastatic renal cell carcinoma: success dependant on risk factors?
Huland E; Heinzer H; Huland H
Hepatogastroenterology; 1999 May; 46 Suppl 1():1257-62. PubMed ID: 10429971
[TBL] [Abstract][Full Text] [Related]
6. [A case of interferon-alpha-resistant renal cell carcinoma responding to interleukin-2 therapy].
Kobori G; Yamada H; Higashi Y
Hinyokika Kiyo; 2008 Oct; 54(10):657-9. PubMed ID: 19048930
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of renal cell carcinoma with mediastinal lymph node metastasis by interleukin-2: a case report.
Tokunaga M; Masuda A; Mukai M; Nakamura H; Iwaki K; Terachi T
Tokai J Exp Clin Med; 2005 Jul; 30(2):111-5. PubMed ID: 16146201
[TBL] [Abstract][Full Text] [Related]
8. [Successful treatment for renal cell carcinoma with lung metastases by interleukin-2 and interferon-alfa: a case report].
Sakata Y; Ogura Y; Wakita T; Hayashi N; Sugimura Y
Hinyokika Kiyo; 2003 Jul; 49(7):389-91. PubMed ID: 12968479
[TBL] [Abstract][Full Text] [Related]
9. A comparison of systemic versus inhaled recombinant IL-2 administration for the treatment of metastatic renal cell carcinoma.
Huland E; Heinzer H; Huland H
Folia Biol (Praha); 2000; 46(6):241-50. PubMed ID: 11140857
[TBL] [Abstract][Full Text] [Related]
10. [Individualized therapy with alpha-interferon in metastatic renal cell carcinoma].
Gross AJ; Dieckmann KP; Krain J; Huland H
Urologe A; 1995 Mar; 34(2):158-61. PubMed ID: 7754588
[TBL] [Abstract][Full Text] [Related]
11. [Long-term complete response of multiple lung metastases from renal cell carcinoma induced by combination therapy with interferon alpha and UFT: a case report].
Terachi T; Okada Y; Takeuchi H; Yoshida O
Hinyokika Kiyo; 1993 Apr; 39(4):353-5. PubMed ID: 8503332
[TBL] [Abstract][Full Text] [Related]
12. Regression of pulmonary and multiple skeletal metastases from renal cell carcinoma by nephrectomy and alpha-interferon therapy: a case report.
Ibayashi K; Ando M; Gotoh E
Jpn J Clin Oncol; 1993 Dec; 23(6):378-83. PubMed ID: 8283792
[TBL] [Abstract][Full Text] [Related]
13. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy.
Maruoka M; Fujimura M; Kawamura K; Suzuki S; Hamano M; Nishikawa Y; Nagayama T
Int J Urol; 2005 May; 12(5):442-8. PubMed ID: 15948742
[TBL] [Abstract][Full Text] [Related]
14. Complete remission of renal cell carcinoma with lung metastases in two hemodialysis patients after low-dose interferon therapy.
Nemoto K; Miura T; Shioji G; Tsuboi N
Hemodial Int; 2011 Apr; 15(2):288-92. PubMed ID: 21395974
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for renal cell cancer in the era of targeted therapy.
Coppin C
Expert Rev Anticancer Ther; 2008 Jun; 8(6):907-19. PubMed ID: 18533800
[TBL] [Abstract][Full Text] [Related]
16. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC
Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma.
Donskov F; Bennedsgaard KM; Hokland M; Marcussen N; Fisker R; Madsen HH; Fode K; von der Maase H
Cancer Immunol Immunother; 2004 Aug; 53(8):729-39. PubMed ID: 15088127
[TBL] [Abstract][Full Text] [Related]
18. Treatment of pulmonary metastatic renal-cell carcinoma in 116 patients using inhaled interleukin-2 (IL-2).
Huland E; Heinzer H; Huland H
Anticancer Res; 1999; 19(4A):2679-83. PubMed ID: 10470219
[TBL] [Abstract][Full Text] [Related]
19. [A case of complete regression of metastatic renal cell carcinoma following corticosteroid treatment].
Tanaka M; Fukuda H; Higashi Y
Hinyokika Kiyo; 2003 Apr; 49(4):225-8. PubMed ID: 12784718
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous interleukin-2 and interferon-alpha in metastatic renal cell carcinoma: results of a French regional experience in Languedoc.
Culine S; Iborra F; Mottet N; Avancès C; de Graeve B; Volpé P; Vignoud J; Bringer JP; Marroncle M; Le Pellec L; Ayuso D; Jansen E; Faix A; Rebillard X
Am J Clin Oncol; 2006 Apr; 29(2):148-52. PubMed ID: 16601433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]